Insider Favorites For Growth In January 2025

In This Article:

As global markets navigate a choppy start to 2025, marked by inflation concerns and political uncertainties, investors are keenly watching for opportunities amid fluctuating indices. With U.S. equities experiencing notable declines and small-cap stocks underperforming, the spotlight turns to growth companies with high insider ownership as potential beacons of stability and promise in these turbulent times.

Top 10 Growth Companies With High Insider Ownership

Name

Insider Ownership

Earnings Growth

Seojin SystemLtd (KOSDAQ:A178320)

30.9%

39.9%

People & Technology (KOSDAQ:A137400)

16.4%

37.3%

Archean Chemical Industries (NSEI:ACI)

22.9%

41.2%

SKS Technologies Group (ASX:SKS)

29.7%

24.8%

Kirloskar Pneumatic (BSE:505283)

30.3%

26.3%

Medley (TSE:4480)

34%

27.2%

Brightstar Resources (ASX:BTR)

16.2%

84.3%

Fine M-TecLTD (KOSDAQ:A441270)

17.2%

131.1%

Fulin Precision (SZSE:300432)

13.6%

66.7%

HANA Micron (KOSDAQ:A067310)

18.3%

110.9%

Click here to see the full list of 1474 stocks from our Fast Growing Companies With High Insider Ownership screener.

Let's uncover some gems from our specialized screener.

Pandox

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Pandox AB (publ) is a hotel property company that owns, develops, and leases hotel properties worldwide with a market cap of SEK36.39 billion.

Operations: The company's revenue is derived from two primary segments: Leases, generating SEK3.85 billion, and Own operation, contributing SEK3.23 billion.

Insider Ownership: 11.1%

Pandox's growth potential is underscored by its forecasted annual profit growth, which exceeds the market average, and expected revenue growth of 6.7% per year. However, recent earnings reveal challenges with a net loss in Q3 2024 despite increased nine-month sales. The company's financial position shows interest payments are not well covered by earnings, and dividends are unsustainable at current levels. Insider ownership remains stable with no significant trading activity reported recently.

OM:PNDX B Earnings and Revenue Growth as at Jan 2025
OM:PNDX B Earnings and Revenue Growth as at Jan 2025

Vimian Group

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Vimian Group AB (publ) operates in the global animal health industry and has a market capitalization of approximately SEK20.74 billion.

Operations: The company's revenue is derived from several segments, including Medtech (€112.75 million), Diagnostics (€20.32 million), Specialty Pharma (€163.45 million), and Veterinary Services (€56.11 million).

Insider Ownership: 11.1%